Results 221 to 230 of about 169,700 (260)

Immunomodulatory therapy for inflammatory bowel disease

Journal of Gastroenterology, 2004
Patients with inflammatory bowel disease (IBD) have intestinal and extraintestinal symptoms that can greatly impair their quality of life. They must rely on multiple medications with aminosalicylates, corticosteroids, and purine analogues to control these symptoms.
Kazuo, Kusugami, Kenji, Ina, Takafumi, Ando, Kenji, Hibi, Yuji, Nishio, Hidemi, Goto   +5 more
openaire   +2 more sources

Future directions in immunomodulatory therapy

Medical Oncology, 2009
The role of immunomodulatory-based therapy with thalidomide or lenalidomide is clearly established in the management of patients with myeloma in all phases of their disease. Recent preclinical and clinical works have demonstrated that in addition to combination therapy with dexamethasone, there is significant activity when combined with the proteasome ...
openaire   +2 more sources

Recent developments in immunomodulatory therapy

Journal of Allergy and Clinical Immunology, 1985
The remarkable gains in basic immunologic knowledge have outpaced improvements in available agents or techniques that can be used to clinically modify the immune response. Many biologic and synthetic immunomodifiers, adjuvants, and drugs with both specific and/or nonspecific effects on immunity have been investigated.
openaire   +2 more sources

Immunomodulatory Therapies: Challenges of Individualized Therapy Strategies

2007
"Individualized therapy strategies" involve strategies that allow treatment to be guided by patient-specific conditions. For this, robust biomarkers are needed. Examples of biomarker-guided therapies already in use are the treatment of insulin-dependent diabetes (biomarker: blood glucose level) or the treatment of hypertension (biomarker: blood ...
H D, Volk, B, Sawitzki, F, Kern, C, Höflich, R, Sabat, P, Reinke   +5 more
openaire   +2 more sources

Immunomodulatory Therapies for Renal Cell Carcinoma

Protein & Peptide Letters, 2018
Renal Cell Carcinoma (RCC) is the most common tumor originating from the kidneys. In comparison to other solid tumors, RCC is poorly sensitive to conventional therapeutic modalities. As such, metastatic RCC (mRCC) continues to be associated with high rates of morbidity and mortality. Targeted agents have shown remarkable progress in RCC management with
Min, Liu, Huizi, Wu, Dangang, Shangguan, Yueping, Jiang, Xiangping, Li, Shao, Liu, Boting, Zhou, Tao, Yin, Zhicheng, Gong   +8 more
openaire   +2 more sources

Thalidomide and immunomodulatory drugs as cancer therapy

Current Opinion in Oncology, 2002
The demonstration of increased angiogenesis in cancer pathogenesis prompted the use of thalidomide in both solid tumors and hematologic malignancies. Its broad spectrum of actions besides its antiangiogenic potential, specifically, its immunomodulatory properties, antiinflammatory actions, and direct effect on tumor cells and their microenvironment ...
Noopur, Raje, Kenneth C, Anderson
openaire   +2 more sources

The immunomodulatory role of probiotics in allergy therapy

Journal of Cellular Physiology, 2018
AbstractThe increased incidence of allergic disorders may be the result of a relative fall in microbial induction in the intestinal immune system during infancy and early childhood. Probiotics have recently been proposed as viable microorganisms for the prevention and treatment of specific allergic diseases. Different mechanisms have been considered for
Jafar Hajavi, Seyed‐Alireza Esmaeili, Abdol‐Reza Varasteh, Hossein Vazini, Hadi Atabati, Fatemeh Mardani, Amir A. Momtazi‐Borojeni, Maryam Hashemi, Mojtaba Sankian, Amirhossein Sahebkar   +9 more
openaire   +2 more sources

Principles of Immunomodulatory Therapy

1994
This chapter concerns the principles of immunomodulatory therapy for use in the neurologic intensive care unit (ICU). These principles, which are derived from those generally used for patients receiving immunomodulatory therapy, are particularly important in the ICU.
David R. Cornblath, Reinhard Hohlfeld, Thomas P. Bleck   +2 more
openaire   +1 more source

Vaccines and Immunomodulatory Therapies for Food Allergy

Current Allergy and Asthma Reports, 2011
The apparent increase in food allergy prevalence has led to a surge in the amount of clinical and basic science research dedicated to the field. At the current time, allergen avoidance remains the cornerstone of treatment; however, recent clinical trials investigating various forms of immunotherapy have opened doors to the possible future application ...
Jay A, Lieberman, Anna, Nowak-Węgrzyn
openaire   +2 more sources

Immunomodulatory Therapies in Neurologic Critical Care

Neurocritical Care, 2009
Neurologic disorders with autoimmune dysregulation are commonly encountered in the critical care setting. Frequently encountered diseases include Guillain-Barré syndrome (GBS), myasthenia gravis, multiple sclerosis, acute demyelinating encephalomyelitis, and encephalitides. Immunomodulatory therapies, including high-dose corticosteroids, plasmapheresis,
Logan M, McDaneld, Jeremy D, Fields, Dennis N, Bourdette, Anish, Bhardwaj   +3 more
openaire   +2 more sources